These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30464556)

  • 1. Novel mechanism responsible for high-level macrolide resistance in
    Kasai A; Ohta A; Maeda Y; Yamada K; Tao K; Saito R
    Infect Drug Resist; 2018; 11():2137-2140. PubMed ID: 30464556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanism of macrolide-lincosamide resistance in Moraxella catarrhalis.
    Saito R; Nonaka S; Nishiyama H; Okamura N
    J Med Microbiol; 2012 Oct; 61(Pt 10):1435-1438. PubMed ID: 22820696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and molecular analysis of macrolide-resistant Moraxella catarrhalis clinical isolates in Japan, following emergence of the highly macrolide-resistant strain NSH1 in 2011.
    Kasai A; Ogihara S; Yamada K; Tanimichi Y; Nishiyama H; Saito R
    J Med Microbiol; 2015 Jul; 64(7):708-713. PubMed ID: 25934551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycin.
    Matic V; Kosowska K; Bozdogan B; Kelly LM; Smith K; Ednie LM; Lin G; Credito KL; Clark CL; McGhee P; Pankuch GA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4103-12. PubMed ID: 15504828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrolide resistance in Campylobacter jejuni and Campylobacter coli: molecular mechanism and stability of the resistance phenotype.
    Gibreel A; Kos VN; Keelan M; Trieber CA; Levesque S; Michaud S; Taylor DE
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2753-9. PubMed ID: 15980346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of a 23S rRNA mutation in Mycoplasma hominis associated with a loss of the intrinsic resistance to erythromycin and azithromycin.
    Pereyre S; Renaudin H; Charron A; Bébéar C; Bébéar CM
    J Antimicrob Chemother; 2006 Apr; 57(4):753-6. PubMed ID: 16464889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-Level Macrolide-Resistant Moraxella catarrhalis and Development of an Allele-Specific PCR Assay for Detection of 23S rRNA Gene A2330T Mutation: A Three-Year Study at a Chinese Tertiary Hospital.
    Liu Y; Xu H; Xu Z; Kudinha T; Fan X; Xiao M; Kong F; Sun H; Xu Y
    Microb Drug Resist; 2015 Oct; 21(5):507-11. PubMed ID: 25923017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribosomal Mutations Conferring Macrolide Resistance in Legionella pneumophila.
    Descours G; Ginevra C; Jacotin N; Forey F; Chastang J; Kay E; Etienne J; Lina G; Doublet P; Jarraud S
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28069647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibility and mechanisms of high-level macrolide resistance in clinical isolates of Moraxella nonliquefaciens.
    Nonaka S; Matsuzaki K; Kazama T; Nishiyama H; Ida Y; Koyano S; Sonobe K; Okamura N; Saito R
    J Med Microbiol; 2014 Feb; 63(Pt 2):242-247. PubMed ID: 24196134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in 23S rRNA account for intrinsic resistance to macrolides in Mycoplasma hominis and Mycoplasma fermentans and for acquired resistance to macrolides in M. hominis.
    Pereyre S; Gonzalez P; De Barbeyrac B; Darnige A; Renaudin H; Charron A; Raherison S; Bébéar C; Bébéar CM
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3142-50. PubMed ID: 12234836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage.
    Tait-Kamradt A; Davies T; Cronan M; Jacobs MR; Appelbaum PC; Sutcliffe J
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2118-25. PubMed ID: 10898684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombineering reveals a diverse collection of ribosomal proteins L4 and L22 that confer resistance to macrolide antibiotics.
    Diner EJ; Hayes CS
    J Mol Biol; 2009 Feb; 386(2):300-15. PubMed ID: 19150357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 23S rRNA gene mutations contributing to macrolide resistance in Campylobacter jejuni and Campylobacter coli.
    Ladely SR; Meinersmann RJ; Englen MD; Fedorka-Cray PJ; Harrison MA
    Foodborne Pathog Dis; 2009; 6(1):91-8. PubMed ID: 19014274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae.
    Kosowska K; Credito K; Pankuch GA; Hoellman D; Lin G; Clark C; Dewasse B; McGhee P; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4113-9. PubMed ID: 15504829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in 23S rRNA and ribosomal protein L4 account for resistance in Chlamydia trachomatis strains selected in vitro by macrolide passage.
    Zhu H; Wang HP; Jiang Y; Hou SP; Liu YJ; Liu QZ
    Andrologia; 2010 Aug; 42(4):274-80. PubMed ID: 20629652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae.
    Canu A; Malbruny B; Coquemont M; Davies TA; Appelbaum PC; Leclercq R
    Antimicrob Agents Chemother; 2002 Jan; 46(1):125-31. PubMed ID: 11751122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrolide resistance by ribosomal mutation in clinical isolates of Streptococcus pneumoniae from the PROTEKT 1999-2000 study.
    Farrell DJ; Douthwaite S; Morrissey I; Bakker S; Poehlsgaard J; Jakobsen L; Felmingham D
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1777-83. PubMed ID: 12760848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro selection and characterization of resistance to macrolides and related antibiotics in Mycoplasma pneumoniae.
    Pereyre S; Guyot C; Renaudin H; Charron A; Bébéar C; Bébéar CM
    Antimicrob Agents Chemother; 2004 Feb; 48(2):460-5. PubMed ID: 14742195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial susceptibility and genotyping of
    Zhao F; Liu J; Shi W; Huang F; Liu L; Zhao S; Zhang J
    Antimicrob Resist Infect Control; 2019; 8():18. PubMed ID: 30697421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).
    Wierzbowski AK; Nichol K; Laing N; Hisanaga T; Nikulin A; Karlowsky JA; Hoban DJ; Zhanel GG
    J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.